| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 21 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 16 |
| 2 | TACROLIMUS OINTMENT 0.1% | 16 |
| 3 | PREDNISONE | 12 |
| 4 | MYCOPHENOLIC ACID | 11 |
| 5 | CARBOPLATIN | 9 |
| 6 | MYCOPHENILIC ACID | 9 |
| 7 | DOCETAXEL | 8 |
| 8 | DOCETAXEL ANHYDROUS | 8 |
| 9 | PEMBROLIZUMAB | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TISOTUMAB VEDOTIN | 1 | 0.0010 |
| 1 | MYCOPHENILIC ACID | 9 | 0.0004 |
| 2 | MYCOPHENOLIC ACID | 11 | 0.0003 |
| 3 | DALTEPARIN SODIUM | 2 | 0.0002 |
| 4 | TACROLIMUS | 21 | 0.0001 |
| 5 | TACROLIMUS OINTMENT 0.1% | 16 | 0.0001 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 16 | 0.0001 |
| 7 | DOCETAXEL | 8 | 0.0001 |
| 8 | DOCETAXEL ANHYDROUS | 8 | 0.0001 |
| 9 | VALGANCICLOVIR | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 9 | 0.0004 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 8 | 0.0001 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 3 | Microtubule Inhibitor [EPC] | 8 | 0.0000 |
| 4 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 9 | 0.0000 |
| 6 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Corticosteroid [EPC] | 16 | 0.0000 |